HU00012120090
Cooperative Agreement
Overview
Grant Description
Randomized controlled trial of ivabradine in long-haul COVID-19.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Bethesda,
Maryland
208144799
United States
Geographic Scope
Single Zip Code
Related Opportunity
NOT APPLICABLE
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/31/25 to 03/31/26.
Metis Foundation was awarded
Ivabradine for Long-Haul COVID-19: RCT
Cooperative Agreement HU00012120090
worth $6,603,892
from the Uniformed Services University of the Health Sciences in September 2021 with work to be completed primarily in Bethesda Maryland United States.
The grant
has a duration of 4 years 6 months and
was awarded through assistance program 12.750 Uniformed Services University Medical Research Projects.
Status
(Ongoing)
Last Modified 6/27/25
Period of Performance
9/1/21
Start Date
3/31/26
End Date
Funding Split
$6.6M
Federal Obligation
$0.0
Non-Federal Obligation
$6.6M
Total Obligated
Activity Timeline
Transaction History
Modifications to HU00012120090
Additional Detail
Award ID FAIN
HU00012120090
SAI Number
None
Award ID URI
None
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Other
Other
Awarding Office
HU0001 USUHS
Funding Office
HU0001 USUHS
Awardee UEI
CYYCLBFLP125
Awardee CAGE
78HT3
Performance District
MD-08
Senators
Benjamin Cardin
Chris Van Hollen
Chris Van Hollen
Modified: 6/27/25